FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy

Disclosure: J. Mendell: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. Y. Wang: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. B.A. Olenchock: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron P...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendell, Jeanne, Wang, Yuhuan, Olenchock, Ben A, Podgrabinska, Simona, Pagovich, Odelya E, Oral, Elif A, Brown, Rebecca J, Davis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554650/
http://dx.doi.org/10.1210/jendso/bvad114.068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554650/
http://dx.doi.org/10.1210/jendso/bvad114.068

Ejemplares similares